HMOX1 and graft versus host disease: Mesenchymal stromal cells (MSCs) have immunosuppressive properties partly attributed to the HO-1 pathway and are used in graft vs host disease (GVHD) as a therapeutic strategy by some investigators (Stagg and Galipeau, 2013).